Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIMUSTINE Cause Second primary malignancy? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with NIMUSTINE. This represents 13.5% of all adverse event reports for NIMUSTINE.

5
Reports of Second primary malignancy with NIMUSTINE
13.5%
of all NIMUSTINE reports
1
Deaths
0
Hospitalizations

How Dangerous Is Second primary malignancy From NIMUSTINE?

Of the 5 reports, 1 (20.0%) resulted in death.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIMUSTINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does NIMUSTINE Cause?

Cognitive disorder (7) Growth hormone deficiency (7) Cerebral disorder (6) Myelodysplastic syndrome (6)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Related Pages

NIMUSTINE Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy NIMUSTINE Demographics